Object. Rathke cleft cysts (RCCs) are benign masses arising from the embryological Rathke pouch, and are commonly treated by transsphenoidal surgery. The authors retrospectively compared RCC extent of resection-either gross-total resection (GTR) or decompression-to the primary outcome measure, which was recurrences resulting in repeat surgery, and the secondary outcome measure, which was complications.
R athke cleft cysts (RCCs) are benign sellar cysts, and comprise between 6% and 10% of sellar lesions. 3, 6 They are thought to arise from a remnant of the embryological structure, the Rathke pouch, which is typically positioned between the adenohypophysis and the neurohypophysis. 17 Rathke cleft cysts are found frequently at autopsy, and have been reported to occur in 5%-27% of the population. [11] [12] [13] [14] Although RCCs are nonfunctioning, they can result in neurological and endocrine deficits via mass effect on the pituitary axis, optic chiasm, and surrounding anatomy. 6, 7, 18 As a result, surgical intervention is recommended in symptomatic and at-risk patients, most commonly via a transsphenoidal approach. 1, 3, 4, 10, 15 The extent of resection that produces maximum benefit is still somewhat controversial. 1, 4, 9, 16 Theoretically, a more aggressive resection such as a gross-total resection (GTR) would lead to a lower rate of recurrence than a subtotal resection (STR) or fenestration. However, this benefit has not been proven, and GTR conceivably leads to more complications. 1, 2, 8, 15 Furthermore, STR or fenestration techniques are believed to have fewer complications than a more aggressive resection. 10 To date, there has been no conclusive evidence to show whether decompression of RCCs by fenestration or STR can achieve the same level of relief of mass effect as more aggressive approaches, such as a GTR. Similarly, it is also not fully known whether the rate of recurrence is directly correlated with the amount of tumor remaining postoperatively; that is, if a more aggressive resection will ensure a longer tumor-free period. In our study, we aim to answer these questions. We present a case series of patients with RCC in which these two valid paradigms are compared: GTR versus decompression with regard to cyst recurrence and complications due to surgery.
Methods

Inclusion Criteria
The surgical records of 74 patients treated at the Mayo Clinic were obtained from the neurosurgical and pathological data base, in accordance with institutional review board protocol, based on the key word search "Rathke's Cleft Cyst." The patient histories were then reviewed and pertinent information was collected and analyzed. Inclusion criteria for further analyses of recurrence and complications in this study were as follows: 1) pathologically confirmed RCC following surgery at the Mayo Clinic in Rochester, Minnesota and 2) clear documentation of the extent of resection based on operative reports and postoperative imaging. Based on these criteria, 61 patients were included in analyses of recurrence and complications.
Defining Extent of Resection
In the majority of cases, the extent of resection was explicitly stated by the surgeon as a GTR, STR, or fenestration. In all other cases, patients were grouped based on the surgeon's stated impression of the resection. The STR and fenestration groups together compose the decompression cohort.
Recurrence and Complications
Recurrence was defined as radiological evidence of regrowth of the cystic mass postoperatively, found on followup imaging examinations, or determined based on associated symptoms. Symptomatic recurrence was defined by repeat operation for symptoms. Likewise, a complication was defined as a new postoperative clinical abnormality related to the surgery.
Statistical Analysis
We used JMP 8.02 (JMP, version 8; SAS Institute, Inc.) to process the data, applying nonparametric statistical tests (Fisher exact test) or the Pearson chi-square analysis where appropriate to assess significance. The Student t-test (Mann-Whitney analysis) was used for groups of 2, and ANOVA for continuous variables for more than 2 groups. Kaplan-Meier survival analysis was used to determine differences in recurrence. The mean is expressed ± SD throughout.
Results
Patient Demographic Data
There was a total of 74 patients presenting with RCC to the neurosurgery department at the Mayo Clinic in Rochester, Minnesota, within the time frame of this study. The mean patient age at the time of the initial treatment was 42.8 ± 17.4 years (range 13-74 years). Fifty-two patients (70%) were female (mean age 42 years), and 22 (30%) were male (mean age 46 years). In 6 patients the RCC was clinically managed, and they never received surgical treatment, whereas the remaining 68 patients underwent a total of 78 surgical procedures. The mean and median follow-up time for surgically treated patients was 60.5 ± 72.1 months and 29.5 months, respectively, based on last clinical contact (Table 1) .
Symptoms at Presentation
Of the initial 74 patients in this study, the most common presenting symptoms were headache (57%), lethargy (18%), amenorrhea (15%), diabetes insipidus ([DI] 14%), panhypopituitarism (14%), galactorrhea (12%), impotence (12%), libido changes (11%), dizziness (8%), and oligomenorrhea (8%) ( Table 2) . Eight of the patients (11%) were diagnosed following incidental detection on workup for other conditions. Formal preoperative visual field perimetry testing demonstrated that 18 (29%) of the 62 patients tested had visual field deficits. Assessment of laboratory values in symptomatic patients who warranted testing revealed that 41% had some preoperative anterior pituitary deficiency, although only 27% presented in this manner. Preoperative Imaging Figure 1 demonstrates a typical appearance of a symptomatic RCC, which were most often hyperintense on T1-and T2-weighted MR images, and isointense on CT scans. Only 1 case was described as calcified. In addition, RCCs were frequently described as cysts with rim enhancement, indicative of either the cyst wall or compressed normal pituitary. The mean size of cysts preoperatively at their maximum diameter was 16.9 ± 17.8 mm. Fifty-seven (77%) of the 74 RCCs were primarily located in the sella turcica, with 4 (5%) of 74 being primarily suprasellar. Thirty-two (43%) of 74 intrasellar cysts had secondary suprasellar extension, with 4 (5%) extending into the hypothalamic area.
Surgical Data
Six (8%) of 74 patients were clinically observed rather than surgically treated, due to lack of severity of symptoms. Sixty (81%), 7 (10%), and 1 (1%) had 1, 2, or 4 surgeries, respectively. Sixty-four (94%) of these 68 patients had transsphenoidal surgery, whereas the others had craniotomies. Sixty-one patients who underwent surgery had clear documentation of the extent of resection by the surgeon. Of these, 32 (52.5%) underwent a GTR. The remainder underwent decompression. Sixteen (26.2%) of 61 procedures were classified as STRs, and 13 (21.3%) as fenestrations.
Primary Outcome: Recurrence
Eleven (18%) of 61 surgically treated patients with RCCs who met the inclusion criteria were found to have a recurrence. Furthermore, 8 (13%) of 61 patients in this population required a repeat operation for symptomatic recurrence. The mean time to recurrence was 6.4 ± 5.8 months for patients who underwent GTR and 9.1 ± 5 months for patients who underwent decompression (p = 0.4), with the longest time to recurrence being 180 and 120 months, respectively. There was no significant difference in rate of recurrence or repeat surgery among the different resection groups (7% GTR, 10% STR, 2% fenestration; p = 0.06) (Fig. 2) . Four repeat operations for recurrences and repairs (50%) were performed in patients who received STR, whereas GTR and fenestration accounted for 3 (38%) and 1 (13%) each, respectively. Also, 4 (25%) of 16 patients undergoing an STR required a second operation, whereas 3 (9%) of 32 and 1 (8%) of 13 with GTR and fenestration, respectively, required a second operation (p = 0.26). Comparing GTR to decompression, there were no significant differences in rate of recurrence (13% with GTR vs 24% with decompression; p = 0.24) or in rate of repeat operation (9% with GTR vs 17% with decompression; p = 0.36) ( Table 3 ). The mean follow-up times for GTR and decompression were 77.5 ± 83.6 months and 43.3 ± 56 months, respectively (p = 0.07). The inset is a magnified view of the first 10 months and a y-axis amplification (85%-100%). All data combined are represented by the solid gray line (not present in the magnified view). There was no significant difference in the repeat surgery rate by either Wilcoxon or log-rank analysis. Furthermore, if cases are separated into GTR, STR, and fenestration, there is also no significant difference in repeat operation for symptomatic RCC. Dec = decompression (STR and fenestration combined).
Secondary Outcome: Complications
There were no major complications following surgery. In analyzing these cohorts with respect to minor complications following surgery, 11 (34%) of patients with GTR had complications, and in 3 (10%) of those who underwent decompression the surgery was associated with complications; this difference was significant (p = 0.03). Likewise, 79% of all complications (11 of 14) were associated with GTR. Interestingly, all but one of the complications occurred in females. There was a total of 6 cases of sustained or transient DI postoperatively, 5 of which occurred following GTR. Gross-total resection also was associated with all 5 cases of CSF leaks (p = 0.03), and with the only case of syndrome of inappropriate antidiuretic hormone, whereas decompression was associated with the sole case of postoperative hemorrhage (Table 4) .
Visual Field Changes
Eight (47%) of 17 patients with confirmed preoperative visual deficits (for whom a postoperative perimetry study was also available) regained normal vision. The others were either stabilized (6 patients) or showed improvement (3). There were 2 new cases of deficits due to surgery, one each from the GTR and decompression groups.
Pituitary Hormone Data
Preoperative laboratory studies in these patients showed normal mean levels for prolactin (PRL) in females, at 26.5 ± 26.2 ng/ml (range 3.6-130 ng/ml), as well as normal levels for males, at 18 ± 33.6 ng/ml (range 3.3-150 ng/ml); the reference range is 4-30 ng/ml. Fourteen (23.7%) of the 59 patients in whom PRL data were available had hyperprolactinemia preoperatively. Postoperative laboratory studies revealed a decrease in the mean PRL level for females to 23.4 ± 19.3 ng/ml (range 6-79 ng/ml), but an increase for males to 34.1 ± 42.6 ng/ml (range 3.7-109 ng/ml). The mean pre-and postoperative cortisol levels were within the normal reference range (Table 5 ). Hyperprolactinemia resolved postoperatively in 57.1% of those undergoing GTR and in 100% of those undergoing decompression (not significant). However, there was a significant increase in the rate of new postoperative hyper prolactinemia between groups (GTR 8.3%, decompression 0%; p = 0.03). For patients with low total T 4 or morning cortisol preoperatively, there was no significant difference in the rate of cure, defined as resolution of anterior pituitary axis endocrine abnormality, between GTR and decompression. Likewise, there was no significant difference in the incidence of new abnormalities postoperatively between groups for these hormones (Table 6 ).
Discussion
Rathke cleft cysts can be treated by GTR, STR, or fenestration-the first and last being the most and least aggressive treatments, respectively. We present a study aimed at examining the most efficacious manner of surgically removing these masses, with regard to both recurrence and surgical complications. We retrospectively analyzed data from patients treated at our institution who received a pathologically confirmed diagnosis of RCC. The patient demographic data are in line with previously reported studies of comparable size; a mean age of 42 years, and 70% of patients were female (range in the literature: 34-41 years, and 52%-79% female). 1, 3, 8, 10, 14, 15 The primary outcome measure with regard to extent of resection was radiographic and symptomatic recurrence. Secondarily, the rates of surgical complications were assessed. An important difference in this study compared with others with significant numbers of cyst fenestrations is that there were no cases of absolute alcohol instillation into the residual cyst, which has been considered to be an important adjuvant to incompletely resected RCCs. 1, 3, [8] [9] [10] 15 Postoperative Recurrence Assessing the surgical data available for the 61 patients who met our inclusion criteria, we found that the overall rate of recurrence of 18% was consistent with the existing literature. 1, 3, 8, 10, 14, 15 In our study, we found no significant difference in the rate of repeat surgery (symptomatic recurrence) among the 3 treatment modalities. It should be noted that STR accounted for 50% of repeat operations, despite accounting for only 25% of the patients. This difference, however, was not significant, but may be related to a poor power (only 61 patients) to detect this difference. To address this, we assessed STR and fenestration together as a cohort of less aggressive surgeries (decompression) in comparison with GTR. Likewise, we found no significant difference in the rate of either recurrence or repeat operation. This finding is in line with recently published results. 1, 3 In a study by Aho et al. looking at outcomes in a large series of patients with RCCs, the authors concluded that there was no difference in rate of recurrence between radical and less radical resections. These groups would be comparable to the GTR and STR/ fenestration cohorts presented here. Although the conclusions are similar to our study, the work of Aho et al. included alcohol instillation in their regimen of less radical resection, which confounds direct comparison. There is evidence to suggest that alcohol instillation is not innocuous. 5 Despite this supplementary treatment, the results of the 2 studies are similar, suggesting that the addition of alcohol instillation is not needed. Wait et al., 15 in an RCC series looking at endocrinopathies in 77 patients, also found that GTR did not lower the rate of recurrence. However, the vast majority of surgeries in that study were GTRs (67 of 77). Our study is unique in contrast to these prior studies because one of them (Aho et al.) is weighted heavily toward fenestration, and the other (Wait et al.) is composed mostly of GTRs, whereas our experience is more evenly divided between more aggressive and less aggressive procedures, and may be more appropriate in answering questions regarding extent of resection.
Postoperative Complications
With regard to complications following surgery, GTR carried a significantly greater overall risk of complications, and this finding has been confirmed by other authors.
1,3 A similar study found that very aggressive treatment resulted in a high rate of postoperative DI (42%) compared with less aggressive treatment modalities (9%) in patients with RCCs. 1 We conducted a very thorough assessment of postoperative complications to elucidate further the difference in outcomes, and found that GTR carried a 16% risk of DI, whereas the risk related to decompression was only 3%. Similarly, CSF leaks were also increased in patients undergoing GTR. Nearly half of the patients with preoperative visual deficits regained normal vision. This is consistent with other studies demonstrating high rates of visual recovery, with low risk of further damage to the chiasm.
1,15
Pituitary Hormone Deficiency
Pituitary deficiency, in this series, was the third leading symptom at presentation. As was the case in several other studies, 70% of our patient population with RCCs was female, and hyperprolactinemia was often present. 1, 10, 15 In their study, Wait et al. reported a normalization of PRL levels in symptomatic patients following cyst resection. Similarly, there was a 70% resolution of hyperprolactinemia following surgery in our series. Although there was no significant difference in the rate of cure between GTR and decompression in this series, we did find that GTR resulted in a significantly increased rate of new postoperative hyperprolactinemia compared with decompression.
Predictors of Recurrence
Although extent of resection does not appear to correlate with an increased risk of recurrence in RCCs, identification of factors that do give insight is warranted. Squamous metaplasia has been reported as one such factor. 1, 15 There was 1 case of squamous metaplasia noted, which was in the only patient requiring 4 surgeries. Consistent with previous recommendations to follow these lesions by MR imaging yearly for 10 years, we found a recurrence at 12 years (although on average they tended to present within 1 year), and this recommendation seems valid. Moreover, we could not determine any factors, including preoperative size of the mass, presenting symptoms, and endocrine or visual deficits that would account for this bias.
Conclusions
Patients with RCCs appear to require repeat surgery in 13% of cases, and attempted GTR does not appear to reduce the overall rate of recurrence. However, more aggressive resections are associated with more complications in this series, namely hyperprolactinemia, DI, and CSF leaks.
